<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02869984</url>
  </required_header>
  <id_info>
    <org_study_id>1604-095-755</org_study_id>
    <nct_id>NCT02869984</nct_id>
  </id_info>
  <brief_title>Clinical Trial Assessing 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Anterior Resection Syndrome</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dong-A ST</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <brief_summary>
    <textblock>
      Poor functional outcomes has been reported inevitably, and up to 90% of the patients have
      experienced bowel habit changes after sphincter-saving surgery for rectal cancer. But,
      currently there has been no specific treatment for ARS and symptom based empirical management
      is tried Recently, 5-HT3 receptor antagonists can be used for treatment of IBS-D, and has
      been revealed to be slowing the bowel movement and improving stool consistency and urgency.

      We performed the clinical trial with using ramosetron (IrribowÂ®) for the treatment of ARS
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>August 2016</start_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>low anterior resection syndrome score</measure>
    <time_frame>4 weeks</time_frame>
    <description>questionnaire with comparison of frequency or urgency</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life score</measure>
    <time_frame>4 weeks</time_frame>
    <description>EORTC QLQ C30 (Korean version, validated)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Anterior Resection Syndrome</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ramosetron treatment for 4 weeks from 1mo after anterior resection for rectal cancer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ramosetron</intervention_name>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patients who undergo sphincter saving surgery for rectal cancer

        Exclusion Criteria:

          -  recurred rectal cancer

          -  rectal cancer with distant metastasis

          -  permanent stoma formation

          -  postoperative concurrent chemoradiotherapy

          -  uncontrolled medical disease

          -  inflammatory bowel disease

          -  uncontrolled constipation

          -  preoperative incontinence (LARS score, more than 20)

          -  allergic to intervention drug
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kyu Joo Park, MD, PhD</last_name>
    <phone>+82-2-2072-2901</phone>
    <email>kjparkmd@plaza.snu.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Seung-Bum Ryoo, MD</last_name>
    <phone>+82-2-2072-4847</phone>
    <email>sbryoomd@gmail.com</email>
  </overall_contact_backup>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 10, 2016</study_first_submitted>
  <study_first_submitted_qc>August 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 17, 2016</study_first_posted>
  <last_update_submitted>August 12, 2016</last_update_submitted>
  <last_update_submitted_qc>August 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Kyu Joo Park</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ramosetron</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

